F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Chronological Source Flow
Back

AI Fusion Summary

US FDA grants early access authorization for Revolution Medicines’ pancreatic cancer pill, allowing patients to receive the treatment ahead of full approval. The decision follows clinical data demonstrating potential benefits for pancreatic cancer patients.
01/05 19:17 nytimes.com
3 Πηγές
01/05 19:54 investing.com
01/05 20:00 investing.com
Comments
Loading...
0